Clinical Trial Update: Adaptive Radiotherapy for Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on adaptive radiotherapy for head and neck cancers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharynx Cancer
• Larynx Cancer
• Nasopharynx Cancer
• Oral Cavity Cancer
• Oropharynx Cancer
• Paranasal Sinus Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer, Paranasal Sinus Cancer | Phase 2 | Status: COMPLETED